Sale Alert!

Check out our latest deals! NEOPAR®

  Home > Breeder Direct > Vaccines / Syringe & Needles > Merck Dog Vaccines (Intervet & Schering Plough) >

Nobivac: Intra-Trac III ADT
Intra-Trac III ADT

Avirulent Live Culture, Modified Live Virus

Item# Item Name Our Price Qty Add
10-022347 Nobivac: Intra-Trac III ADT 150X1
10-022349 Nobivac: Intra-Trac III ADT 25X1
Check the items you wish to purchase, then click

Features & Benefits * Low volume dose - 0.5 mL of the ADT (Advanced Delivery Technology) product for improved administration * Easy one nostril application * Unique needle-less administration with Advanced Delivery Technology (ADT®), no risk of accidental injection * Can be given to puppies 3 weeks old * Does not interfere with maternal antibodies to Bordetella * Offers broad protection against more agents of canine cough * Early onset of immunity starting as early as 48 hours post application * Available in 25 and 150 dose presentations * IntraTrac 3 is also available in regular vial presentations of 25 and 150 doses.This product offers the option of diluting the freeze dried portion with 0.5 or 1.0 ml of diluent. * Comprehensive service package: – vaccination guides – pet passports – myvetonline practice building website * Comprehensive technical support package: – Vaccine Protocol Help Line: 1-866-437-7955 – VetConnX teleconferences – VetConnX topics Indications Intra-Trac® 3/ADT is recommended for use as an aid in the prevention of disease associated with canine parainfluenza virus, Bordetella bronchiseptica and canine adenovirus type 2 infection in healthy dogs 3 weeks of age or older

INTRA-TRAC® 3 ADT† Schering-Plough Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine Modified Live Virus, Avirulent Live Culture †(Advanced Delivery Technology) DIRECTIONS FOR USE - PLEASE READ CAREFULLY Intra-Trac 3 ADT vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. WHEN TO VACCINATE Vaccinate dogs at 3 weeks of age or older. Annual revaccination is recommended. PREPARATION OF THE VACCINE 1. Hold the vaccine vial in an upright position. Flip the top up and pull to the left. The tear-off aluminum seal is connected to the flip top and will be easily removed. Remove, but do not discard the rubber stopper. 2. Hold the nasal applicator in an upright position and pull off the tip. 3. Carefully insert the tip of the nasal applicator into the upright vaccine vial. 4. Gently squeeze the diluent out of the nasal applicator into the vaccine vial. Do not discard the nasal applicator. 5. Replace the rubber stopper on the vaccine vial and shake gently until the vaccine is fully rehydrated. 6. Remove the rubber stopper from the vaccine vial and insert the end of the nasal applicator into the upright vaccine vial. 7. Gently squeeze and release the nasal applicator so that the rehydrated vaccine is drawn back into the nasal applicator. 8. While holding the nasal applicator in an upright position, slide a nasal applicator tip over the end of the nasal applicator. 9. The vaccine is now ready for use. DOSAGE AND ADMINISTRATION The recommended dose is 0.5 mL of rehydrated vaccine administered intranasally. The vaccine is instilled using an applicator tip. By gently squeezing the body of the nasal applicator, squirt the rehydrated vaccine into one or both nostrils or the dog. CAUTION 1. THIS PRODUCT IS DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED DILUENT. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence, jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs, monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin, tetracycline or trimethoprim/sulfa may be indicated. If anaphylactoid reaction occurs, use epinephrine. 2. Post vaccinal reactions consisting of mild canine cough syndrome may occur following use of this vaccine. 3. For veterinary use only. Store at 2° to 7°C (35° to 45°F). Do not freeze. Use entire contents when first opened. Burn all nasal applicators, vaccine vials and all unused contents. 4. This vaccine contains penicillin, streptomycin and nystatin as preservatives. For use in dogs only. FOR INTRANASAL USE ONLY. U.S. Veterinary License No. 165A Schering-Plough Animal Health Corp., Omaha, Nebraska 68103, USA 1 800 224-5318 (USA) 1 888 306-0069 (Canada) © Copyright 2002 Schering-Plough Animal Health Corp. All rights reserved. ® Registered Trademark P13950-11, P13948-10 NDC 25x1 Dose Vials of Vaccine 0061-1407-01 P13947-11 150x1 Dose Vials of Vaccine 0061-1407-02 P13949-11 NAC No.: 10472390

Share your knowledge of this product with other customers... Be the first to write a review

Browse for more products in the same category as this item:

Breeder Direct > Vaccines / Syringe & Needles > Merck Dog Vaccines (Intervet & Schering Plough)
Breeder Direct > Vaccines / Syringe & Needles > Dog - Kennel Cough Vaccines
Pet Direct > Pet Vaccines > Kennel Cough Vaccines

Social Tab
Are you a fan of A to Z Vet Supply?
Hide Bar

Read our latest blog post...